Home > Analytics > GENERIC PHARMASEC

GENERIC PHARMASEC
Intrinsic Value | Fundamental Analysis

BOM : 531592     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Sep 27,2022
Price(EOD): ₹ 4.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Dyes & Pigments
MCap: ₹ 113.53 Cr
Value of ₹ 1 Lac invested in GENERIC PHARMASEC
on Nov 08,2017 (price: ₹ 4.34)

₹ 1 L

₹ 0.95 L

1W : -4.8% 1M : 5.3% 1Y : -45.3%
COMMUNITY POLL
for GENERIC PHARMASEC
Please provide your vote to see the results
GENERIC PHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
GENERIC PHARMASEC -4.8% 5.3% -45.3%
SUDARSHAN CHEMICAL INDUSTRIES -7.9% -8.1% -35%
KIRI INDUSTRIES 2.7% 5.8% -5.3%
VIDHI SPECIALTY FOOD INGREDIENTS -4% 5.4% 7.7%
BODAL CHEMICALS -5.4% -6.6% -17.9%
BHAGERIA INDUSTRIES -10.1% 2.3% -26.9%
SHREE PUSHKAR CHEMICALS & FERTILISERS -11.4% -5% 6.6%
DYNEMIC PRODUCTS -4.5% -16.1% -45.7%
ASAHI SONGWON COLORS -3.2% 0.6% -14.2%

FUNDAMENTAL ANALYSIS OF GENERIC PHARMASEC

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF GENERIC PHARMASEC

 
Valuation Score
[As on : Sep 27,2022 ]

Ratio Standalone
P/E
P/B
P/S
-199.84
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -0.57 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

5.49
P/B Calculated based on Book Value of Rs 20.66 Cr
[Latest Year - Mar2021 - Standalone Results ]

4.35
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

Financial Ratios →

Insights 💡 GENERIC PHARMASEC is one of the potential top 17% undervalued companies ! Discover More →

FAIR VALUE OF GENERIC PHARMASEC

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
35%
-74%
-97%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GENERIC PHARMASEC



GENERIC PHARMASEC vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GENERIC PHARMASEC

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GENERIC PHARMASEC

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GENERIC PHARMASEC

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-7.57%
-15.42%
-9.28%
-630%
-15.14%
-265.71%
-208.72%
-247.22%
QtrlyTrend
-8
Latest Qtr: Jun2022
Quarterly Result Analysis →


GENERIC PHARMASEC related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about GENERIC PHARMASEC


Is GENERIC PHARMASEC good for long term investment?

As on Sep 27,2022, the Fundamentals of GENERIC PHARMASEC look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of GENERIC PHARMASEC . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GENERIC PHARMASEC UnderValued or OverValued?

As on Sep 27,2022, GENERIC PHARMASEC is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GENERIC PHARMASEC ?

As on Sep 27,2022, the Intrinsic Value of GENERIC PHARMASEC is Rs. 16.06 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 3.04
Fair Value [Median EV / Sales Model] : Rs. 16.06
Fair Value [Median Price / Sales Model] : Rs. 158.37
Estimated Median Fair Value of GENERIC PHARMASEC : Rs. 16.06

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is GENERIC PHARMASEC trading at a Premium or Discount?

As on Sep 27,2022, GENERIC PHARMASEC is trading at a Discount of -74% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].